Papillary thyroid carcinoma: Modified radical neck dissection improves prognosis

Archives of Surgery

Volumn 133, Issue 3, 1998, Pages 276-280

  Noguchi, Shiro ^a,c   Murakami, Nobuo ^a   Yamashita, Hiroto ^b   Toda, Masakatsu ^a   Kawamoto, Hitoshi ^a  

^a Hospital Foundation   (Japan)

^b OITA UNIVERSITY   (Japan)

^c Hospital Foundation   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INVASION; CANCER RISK; CANCER SURVIVAL; CLINICAL ARTICLE; HUMAN; LYMPH NODE METASTASIS; NECK DISSECTION; PRIORITY JOURNAL; PROGNOSIS; SURGICAL TECHNIQUE; THYROID PAPILLARY CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; ANALYSIS OF VARIANCE; CARCINOMA, PAPILLARY; FEMALE; HUMANS; MALE; MIDDLE AGED; NECK DISSECTION; RISK FACTORS; SURVIVAL ANALYSIS; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 0031978031     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.133.3.276     Document Type: Article

References (43)

1. Simon D, Goretzki PE. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg. 1996;20:860-866.
2. Scheumann GSW, Gimm O, Wegener G, et al. Prognostic significance and surgical management of locoregional lymph node metastasis in papillary thyroid cancer. World J Surg. 1994;18:559-568.
3. Noguchi S, Noguchi A, Murakami N. Papillary carcinoma of the thyroid, I: developing pattern of metastasis. Cancer. 1970;26:1053-1060.
4. Noguchi S, Murakami N. The value of lymph-node dissection in patients with differentiated thyroid cancer. Surg Clin North Am. 1987;67:251-261.
5. Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med. 1981;70:511-518.
6. DeGroot LJ, Kaplan EL, McCormick M, et al. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 1990;71:414-424.
7. McConahey WM, Hay ID, Woolner LB, et al. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc. 1986;61:978-996.
8. Cunningham MP, Duda RB, Recant W, et al. Survival discriminants for differentiated thyroid cancer. Am J Surg. 1990;160:344-347.
9. Salvensen H, Njolstad PR, Akslen LA, et al. Thyroid carcinoma: results from surgical treatment in 211 consecutive patients. Eur J Surg. 1991;157:521-526.
10. McHenry CR. Prospective management of nodal metastases in differentiated thyroid cancer. Am J Surg. 1991;162:353-356.
11. Proye C, Carnaille B, Vix M, et al. Récidives ganglionaires des cancers thyroïdiens opéré: de l'inutilité du curage ganglionaire de principe (carcinomes medullaires ecclus). Chirurgie. 1992;118:448-452.
12. Tisell L-E, Nilsson B, Mölne J, et al. Improved survival of patients with papillary thyroid cancer after surgical microdissection. World J Surg. 1996;20:854-859.
13. Simpson WJ, McKinney SE, Carruthers JS, et al. Papillary and follicular thyroid cancer: prognostic factors in 1578 patients. Am J Med. 1987;83:479-488.
14. Rossi RD, Cady B, Silverman ML, et al. Current results of conservative surgery for differentiated thyroid carcinoma. World J Surg. 1986;10:612-622.
15. Vickery AJ, Wang CA, Walker AM. Treatment of intrathyroidal papillary carcinoma of the thyroid. Cancer. 1987;60:2587-2595.
16. Udelsman R, Lakatos E, Landenson P. Optimal surgery for papillary thyroid carcinoma. World J Surg. 1996;20:88-93.
17. Tubiana M, Schlumberger M, Rougier P. Long-term results and prognostic factors in patients with differentiated thyroid cancer. Cancer. 1985;55:794-804.
18. Bacourt F, Asselain B, Savoie JC, et al. Multifactorial study of prognostic factors in differentiated thyroid carcinoma and a re-evaluation of importance of age. Br J Surg. 1986;73:274-277.
19. Kerr DJ, Burt AD, Boyle P, MacFarlane GJ, Storer AM, Brewin TB. Prognostic factors in thyroid tumours. Br J Cancer. 1986;54:475-482.
20. Noguchi S, Murakami N, Kawamoto H. Classification of papillary cancer of the thyroid based on prognosis. World J Surg. 1994;18:552-557.
21. Bacourt F, Asselain B, Svoiet JC, et al. Multifactorial study of prognostic factors in differentiated thyroid carcinoma and reevaluation of importance of age. Br J Surg. 1986;73:274-277.
22. Carcangiu ML, Zampi G, Pupi A, et al. Papillary carcinoma of the thyroid: a clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer. 1985;55:805-828.
23. Sellers M, Beeken S, Blankenship A, et al. Prognostic significance of cervical lymph node metastasis in differentiated thyroid cancer. Am J Surg. 1992;164:578-581.
24. Cady B, Sedgwick CE, Meissner WA, Wool MS, Salzman FA, Werber J. Risk factor analysis in differentiated thyroid carcinoma. Cancer. 1979;43:810-820.
25. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: developing a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993;114:1050-1057.
26. Samaan NA, Maheshwari YK, Nader S, et al. Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. J Clin Endocrinol Metab. 1983; 56:1131-1138.
27. Beenken S, Guillamondegui O, Shallenberger R, et al. Prognostic factors in patients dying of well-differentiated thyroid cancer. Arch Otolaryngol Head Neck Surg. 1989;115:326-330.
28. Frankenthaler RA, Sellin RV, Cangir A, et al. Lymph node metastasis from papillaryfollicular thyroid carcinoma in young patients. Am J Surg. 1990;160:341-343.
29. Rosen IB, Maitland A. Changing the operative strategy for thyroid cancer by node sampling. Am J Surg. 1983;146:504-508.
30. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 1988;104:947-953.
31. Tscholl DJ, Hedinger CE. Papillary thyroid carcinomas: morphology and prognosis. Virchows Arch [Pathol Anat]. 1982;396:19-39.
32. Ahuja S, Ernst H, Lenz K. Papillary thyroid carcinoma: occurrence and types of lymph node metastases. J Endocrinol Invest. 1991;14:543-549.
33. Attie NJ, Khafif AR, Sleckler MR. Elective neck dissection in papillary carcinoma of the thyroid. Am J Surg. 1971;122:464-471.
34. Clark OH. Total thyroidectomy: the treatment of choice for patients with differentiated thyroid cancer. Ann Surg. 1982;196:361-370.
35. Reeve TS, Delbridge L, Crummer P. Total thyroidectomy in the management of differentiated thyroid cancer: a review of 258 cases. Aust N Z J Surg. 1986;56: 829-833.
36. Schroder DM, Chambors A, France CJ. Operative strategy for thyroid cancer: is total thyroidectomy worth the price. Cancer. 1986;58:2320-2328.
37. Shah JP, Loree TR, Dharker D, et al. Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched-pair analysis. Am J Surg. 1993; 166:331-335.
38. Hoie J, Stenwig AE, Brennhovd IO. Surgery in papillary thyroid carcinoma: a review of 730 patients. J Surg Oncol. 1988;37:147-151.
39. Tourniaire J, Bernard AM, Adeleine P, et al. Les éléments du prognostic des cancers thyrïdiens différenciés: 536 observations. Ann Endocrinol (Paris). 1989;50: 219-224.
40. Starnes HF, Brooks DC, Pinkus GS, et al. Surgery for thyroid carcinoma. Cancer. 1985;55:1376-1381.
41. Samaan NA, Schultz PN, Hickey RC, et al. The results of various modalities of treatment of well differentiated thyroid carcinoma: a retrospective review of 1599 patients. J Clin Endocrinol Metab. 1992;75:714-720.
42. McDermott MT, Kidd GS, Blue P, et al. Reduced bone mineral content in totally thyroidectomized patients: possible effect of calcitonin deficiency. J Clin Endocrinol Metab. 1983;56:936-939.
43. Coburn MC, Wanebo H. Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am J Surg. 1992;164:671-676.